← FDA Drug Approvals (Drugs@FDA)

ALYFTREK

NDA · New Drug Application · Sponsor: VERTEX PHARMS INC · Approved 2024-12-20

Drug application

FDA Application #

NDA218730

Application type

New Drug Application

Brand name

ALYFTREK

Generic name

VANZACAFTOR, TEZACAFTOR, AND DEUTIVACAFTOR

Active ingredients

DEUTIVACAFTOR; TEZACAFTOR; VANZACAFTOR CALCIUM

Dosage form

TABLET

Route

ORAL

Marketing status

Prescription

Sponsor

VERTEX PHARMS INC

Manufacturer

Vertex Pharmaceuticals Incorporated

First approval

2024-12-20

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown